Clinical Ventures

Finding solutions at the intersection of care delivery and healthcare coverage

Sandbox Clinical Ventures invests in innovations that improve medical care.

OUr thesis

We build partnerships between providers, payors, and entrepreneurs to accelerate improvement in care delivery. We deliver value beyond capital at all stages of innovation, from pre-approval through commercialization.

Fund focus

Stage

Seed through growth stage. We lead rounds and take board seats, and we invest both before and after regulatory approval and before and after commercialization.

Investment scope

Precision medicine, diagnostics, devices, and AI applied to diagnosis, treatment, and clinical trials. We do not invest in biotech or therapeutics.

Geography

Global, with a focus on North America, Europe, and Asia Pacific. We look to invest in companies where our Limited Partner base is active.

Curated access

Our portfolio companies work directly with payors, hospital systems, and other strategic partners to align solutions with real-world healthcare priorities and accelerate commercial growth.

Portfolio

Companies advancing how care is delivered

Big Health

Clinical Ventures

Offers a digital cognitive behavioral therapy (CBT) platform addressing insomnia, generalized anxiety disorder (GAD), and depression.

Big Health

Cirtiq

Clinical Ventures

Independent verification for all clinical orders

Cirtiq

Humata Health

Clinical Ventures

AI-enabled prior authorization automation software platform for providers and payors.

Exited

Humata Health

Noctrix Health

Clinical Ventures

Offers a non-invasive, drug-free device used in the treatment of restless leg syndrome (RLS).

Exited

Noctrix Health

PinkDx

Clinical Ventures

Developing minimally-invasive diagnostics solution for gynecological cancers.

PinkDx

The Sandbox Clinical Ventures Fund was formed as an affiliate of the Blue Venture Fund, which has made a commitment to co-invest in all Sandbox Clinical Venture Fund investments

Are you solving for the incumbent's dilemma?